Showing results (1201-1210 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|December 15, 2015
PHLPP phosphatases as a therapeutic target in insulin resistance-related diseasesMarta Letizia Hribal, Elettra Mancuso, Rosangela Spiga, et al.Expert Opinion on Therapeutic Targets|October 26, 2017
Hepatitis B core protein as a therapeutic targetLung-Yi Mak, Danny Ka-Ho Wong, Wai-Kay Seto, et al.Expert Opinion on Therapeutic Targets|October 26, 2017
Challenges for intraventricular hemorrhage research and emerging therapeutic targetsThomas Garton, Ya Hua, Jianming Xiang, et al.Expert Opinion on Therapeutic Targets|September 30, 2016
Targeting IFN-λ: therapeutic implicationsMohammed Eslam, Jacob GeorgeExpert Opinion on Therapeutic Targets|September 17, 2019
The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunityAnne Bärenwaldt, Heinz LäubliExpert Opinion on Therapeutic Targets|February 26, 2019
The use of LP533401 as a therapeutic option for renal osteodystrophy affects, renal calcium handling, vitamin D metabolism, and bone health in uremic ratsDariusz Pawlak, Tomasz Domaniewski, Beata Znorko, et al.Expert Opinion on Therapeutic Targets|February 26, 2019
Current strategies toward safer mu opioid receptor drugs for pain managementAliza T Ehrlich, Brigitte L Kieffer, Emmanuel DarcqExpert Opinion on Therapeutic Targets|November 20, 2018
Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's diseaseFanni A Boros, Péter Klivényi, József Toldi, et al.Expert Opinion on Therapeutic Targets|January 23, 2021
A vasculature-centric approach to developing novel treatment options for glioblastomaHans-Georg Wirsching, Patrick Roth, Michael WellerExpert Opinion on Therapeutic Targets|March 11, 2017
Implications of Toll-like receptors in Ebola infectionAmene Saghazadeh, Nima RezaeiPageof 232